Whereas the role of
immune complexes in mediating renal cell and immune cell activation is well established, the contribution of sequence-specific immunomodulatory actions of the
chromatin part remains unclear. Toll-like receptor-9 (TLR-9) mediates immunostimulatory effects of unmethylated microbial CpG-
DNA. It was hypothesized that hypomethylated CpG-
DNA in vertebrates may have similar effects and may contribute to
disease progression in
lupus nephritis. A synthetic G-rich
DNA, known to block CpG-
DNA effects, was used in this study. In macrophages, G-rich
DNA suppressed CpG-
DNA-but not LPS-induced production of CCL5 in a dose-dependent manner.
Injections of G-rich
DNA suppressed lymphoproliferation induced by CpG-
DNA injections in mice. In MRL(lpr/lpr) mice with
lupus nephritis, labeled G-rich
DNA co-localized to glomerular
immune complexes and was taken up into endosomes of TLR-9-positive infiltrating macrophages. Eleven-week-old MRL(lpr/lpr) mice that received
injections of either saline or G-rich
DNA for 13 wk revealed decreased lymphoproliferation and less autoimmune tissue injury in lungs and kidneys as compared with saline-treated controls. G-rich
DNA reduced the levels of serum dsDNA-specific
IgG2a as well as the renal
immune complex deposits. This was consistent with the blocking effect of G-rich
DNA on CpG-
DNA-induced proliferation of B cells that were isolated from MRL(lpr/lpr) mice. As
oligodeoxyribonucleotide 2114-treated MRL(lpr/lpr) mice were not exposed to exogenous CpG-
DNA, these effects should relate to a blockade of CpG motifs in endogenous
DNA. It is concluded that adjuvant activity of self-
DNA contributes to the pathogenesis of
lupus nephritis. Modulating the CpG-DNA-TLR-9 pathway may offer new opportunities for the understanding and treatment of lupus.